Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Bremer

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|October 25, 2013
Compromised function of natural killer cells in acute and chronic viral hepatitisSebastian Lunemann, David F G Malone, Julia Hengst, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis deltaBenjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, et al.
Hepatology (Baltimore, Md.)|January 23, 2025
TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis DPo-Chun Chen, Katja Deterding, Sophie Anna Engelskircher, et al.
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 21, 2025
Accurate quantification using the new RoboGene HDV RNA Quantification Kit 3.0: A European multicenter studyEvelyn Stelzl, Annemarie Berger, Sandra Ciesek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2021
The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infectionYanqin Du, Olympia E Anastasiou, Benedikt Strunz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2012
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcomeBenjamin Heidrich, Beatriz C Serrano, Ramazan Idilman, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|October 25, 2013
Compromised function of natural killer cells in acute and chronic viral hepatitisSebastian Lunemann, David F G Malone, Julia Hengst, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis deltaBenjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, et al.
Hepatology (Baltimore, Md.)|January 23, 2025
TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis DPo-Chun Chen, Katja Deterding, Sophie Anna Engelskircher, et al.
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 21, 2025
Accurate quantification using the new RoboGene HDV RNA Quantification Kit 3.0: A European multicenter studyEvelyn Stelzl, Annemarie Berger, Sandra Ciesek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2021
The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infectionYanqin Du, Olympia E Anastasiou, Benedikt Strunz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2012
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcomeBenjamin Heidrich, Beatriz C Serrano, Ramazan Idilman, et al.
Pageof 7